Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02619266Phase 3Unknown
Phase 3, randomised, double-blind trial (3 arms), sponsored by Xinqiao Hospital. Primary endpoint: Appetite Visual Analog Scale at Day 15. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02619266.